Author
Listed:
- Zamal Ahmed
(University of Texas, M.D. Anderson Cancer Center
Center for Biomolecular Structure and Function, University of Texas, M.D. Anderson Cancer Center)
- Zahra Timsah
(University of Texas, M.D. Anderson Cancer Center
School of Molecular and Cellular Biology, University of Leeds)
- Kin M. Suen
(University of Texas, M.D. Anderson Cancer Center
School of Molecular and Cellular Biology, University of Leeds)
- Nathan P. Cook
(Rice University
Present address: Laboratory of Cellular Dynamics, Max Planck Institute for Biophysical Chemistry, 37077 Göttingen, Germany.)
- Gilbert R. Lee
(Center for Biomolecular Structure and Function, University of Texas, M.D. Anderson Cancer Center)
- Chi-Chuan Lin
(University of Texas, M.D. Anderson Cancer Center
School of Molecular and Cellular Biology, University of Leeds)
- Mihai Gagea
(University of Texas, M.D. Anderson Cancer Center)
- Angel A. Marti
(Rice University)
- John E. Ladbury
(University of Texas, M.D. Anderson Cancer Center
Center for Biomolecular Structure and Function, University of Texas, M.D. Anderson Cancer Center
School of Molecular and Cellular Biology, University of Leeds)
Abstract
The adaptor protein growth factor receptor-bound protein 2 (Grb2) is ubiquitously expressed in eukaryotic cells and involved in a multitude of intracellular protein interactions. Grb2 plays a pivotal role in tyrosine kinase-mediated signal transduction including linking receptor tyrosine kinases to the Ras/mitogen-activated protein (MAP) kinase pathway, which is implicated in oncogenic outcome. Grb2 exists in a constitutive equilibrium between monomeric and dimeric states. Here we show that only monomeric Grb2 is capable of binding to SOS and upregulating MAP kinase signalling and that the dimeric state is inhibitory to this process. Phosphorylation of tyrosine 160 (Y160) on Grb2, or binding of a tyrosylphosphate-containing ligand to the SH2 domain of Grb2, results in dimer dissociation. Phosphorylation of Y160 on Grb2 is readily detectable in the malignant forms of human prostate, colon and breast cancers. The self-association/dissociation of Grb2 represents a switch that regulates MAP kinase activity and hence controls cancer progression.
Suggested Citation
Zamal Ahmed & Zahra Timsah & Kin M. Suen & Nathan P. Cook & Gilbert R. Lee & Chi-Chuan Lin & Mihai Gagea & Angel A. Marti & John E. Ladbury, 2015.
"Grb2 monomer–dimer equilibrium determines normal versus oncogenic function,"
Nature Communications, Nature, vol. 6(1), pages 1-11, November.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms8354
DOI: 10.1038/ncomms8354
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Zu Ye & Shengfeng Xu & Yin Shi & Xueqian Cheng & Yuan Zhang & Sunetra Roy & Sarita Namjoshi & Michael A. Longo & Todd M. Link & Katharina Schlacher & Guang Peng & Dihua Yu & Bin Wang & John A. Tainer , 2024.
"GRB2 stabilizes RAD51 at reversed replication forks suppressing genomic instability and innate immunity against cancer,"
Nature Communications, Nature, vol. 15(1), pages 1-14, December.
- Michael J. Roy & Minglyanna G. Surudoi & Ashleigh Kropp & Jianmei Hou & Weiwen Dai & Joshua M. Hardy & Lung-Yu Liang & Thomas R. Cotton & Bernhard C. Lechtenberg & Toby A. Dite & Xiuquan Ma & Roger J., 2023.
"Structural mapping of PEAK pseudokinase interactions identifies 14-3-3 as a molecular switch for PEAK3 signaling,"
Nature Communications, Nature, vol. 14(1), pages 1-19, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms8354. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.